Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group, Inc. (Nasdaq: LFST) is a mental healthcare company that focuses on outpatient services and regularly issues news and updates about its operations. The company describes itself as one of the nation’s largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults, and its news flow reflects both its clinical focus and its role as a public company.
On this page, readers can find news items such as quarterly earnings results, financial outlooks and operational metrics. LifeStance’s earnings releases discuss topics like revenue, visit volumes, clinician base, Center Margin, Adjusted EBITDA and Free Cash Flow, along with commentary from management on business performance and guidance. These updates provide insight into how the company’s outpatient mental health services translate into financial and operating results.
LifeStance also publishes announcements about participation in healthcare investor conferences hosted by organizations such as UBS, Morgan Stanley and Goldman Sachs. These releases typically include details about presentation dates, times and webcast availability, and they underscore the company’s ongoing engagement with the investment community.
In addition, LifeStance issues news related to corporate governance, including changes to its board of directors, and survey-based research on mental health topics. For example, the company has shared survey findings on how the holiday season affects mental health, addressing themes like seasonal stress, social pressure, loneliness and family dynamics. Together, these news items offer a view into LifeStance’s financial performance, strategic priorities and perspective on mental health trends.
Investors, analysts and others interested in LFST can use this news feed to follow the company’s regular earnings communications, conference appearances, governance updates and mental health surveys in one place.
LifeStance Health Group, Inc. (Nasdaq: LFST) reported Q4 2022 revenue of $229.4 million, a 21% increase from the prior year, and a full-year revenue of $859.5 million, up 29%. The clinician base grew by 18% to 5,631. Despite the growth, the company recorded a net loss of $46.7 million for Q4 and $215.6 million for the full year, primarily due to stock compensation. Adjusted EBITDA was positive at $10.2 million for Q4 and $52.7 million for the full year. For 2023, LifeStance anticipates revenue between $980 million and $1.02 billion and a Center Margin of $270 to $290 million. The outlook emphasizes a focus on streamlining operations for sustainable growth.
LifeStance Health Group, Inc. (NASDAQ: LFST) will announce its fourth quarter earnings on March 8, 2023, before the market opens. A live earnings conference call will take place at 8:30 a.m. Eastern time on the same day, accessible domestically at 1-800-715-9871 or internationally at 1-646-307-1963, using conference ID 4226236. The call will be available for replay on their Investor Relations website. LifeStance, founded in 2017, is a leading provider of outpatient mental health care, offering services through approximately 600 centers in 32 states, employing around 5,400 mental health professionals.
LifeStance Health (NASDAQ: LFST), a leading provider of outpatient mental health care, has been Certified™ by Great Place to Work® for the second consecutive year. This recognition highlights the company's commitment to enhancing employee experience and workplace culture, as validated by feedback from its staff. Research indicates that employees at Certified workplaces report significantly higher job satisfaction and a fair compensation structure. LifeStance emphasizes mental wellness, financial wellness, and community engagement as key components of its corporate culture.
LifeStance Health Group (NASDAQ: LFST) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, in San Francisco. The presentation will feature CEO Ken Burdick and President Danish Qureshi, starting at 7:30 a.m. Pacific time, and will be moderated by Lisa Gill. The event will be webcast live, with a replay available afterward on the company's Investor Relations website. LifeStance, founded in 2017, is a major provider of outpatient mental health care across the U.S., employing approximately 5,400 mental health professionals.
LifeStance Health Group (NASDAQ: LFST) reported Q3 2022 revenue of $217.6 million, a 25% increase from Q3 2021. The company achieved a net loss of $37.9 million, significantly improved from $120.5 million a year prior, mainly due to $34.9 million in stock-based compensation. Adjusted EBITDA rose 44% to $15.4 million. Despite expanding its clinician base by 24% to 5,431, the company adjusted its 2022 revenue guidance to $845-$850 million, citing lower visit volumes and increased costs. LifeStance continues to focus on growth and operational improvements.
LifeStance Health (NASDAQ: LFST) announces J. Michael Bruff's transition to Business Transformation Officer, effective November 10, 2022, with David Bourdon succeeding him as Chief Financial Officer. This leadership shift aims to strengthen the company's focus on strategic initiatives to enhance operational efficiency and patient experience. Bourdon brings over 20 years of relevant experience from Magellan Health and Cigna, aligning with LifeStance's goals for growth and profitability in mental healthcare services.
LifeStance Health Group, Inc. (NASDAQ: LFST) is set to release its third quarter earnings on November 8, 2022, after market close. A live conference call will follow at 4:30 p.m. ET to discuss the results. Interested participants can join via a dedicated phone line or listen to the live audio webcast available on the LifeStance Investor Relations website. Founded in 2017, LifeStance is a leading provider of outpatient mental health care, employing around 5,200 mental health professionals across 32 states and approximately 600 centers.
LifeStance Health (NASDAQ: LFST) appointed Ken Burdick as CEO and Chairman, effective September 7, 2022, succeeding retiring founder Michael Lester, who will remain a Strategic Advisor. Burdick’s extensive 40-year healthcare experience includes leadership roles at Centene and WellCare. The transition aims to drive growth and enhance care access, supported by Danish Qureshi, now President and COO. LifeStance operates over 600 centers nationwide, employing around 5,200 clinicians, and emphasizes affordable, quality mental healthcare.
LifeStance Health Group, a leading provider of outpatient mental health care, announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference in New York City on September 13, 2022. Key presenters include CEO Michael Lester, COO Danish Qureshi, and CFO J. Michael Bruff. The presentation is scheduled for 9:10 a.m. (Eastern time) and will be webcast live, with a replay available afterward. Established in 2017, LifeStance operates around 600 centers in 32 states, employing about 5,200 professionals to enhance access to mental health services.
LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 2022 revenue of $209.5 million, a 31% increase from the previous year. The total clinician count rose to 5,226, with a net gain of 237 in the quarter. Despite a net loss of $68.7 million, a slight improvement from the prior year's loss, adjusted EBITDA remained steady at $14.6 million. The company expects full-year revenue and center margin towards the lower end of previous guidance due to changes in clinician availability. Full-year adjusted EBITDA guidance was reaffirmed at $63 million to $67 million.